NCT01544686View on ClinicalTrials.gov

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Bloodstream Infection
Interventions
DEVICE

3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV

Patients receive the 3M™ Tegaderm CHG IV securement dressing or the 3M Tegaderm Advanced IV securement dressing after placement of a central venous catheter.

Trial Locations (5)

10117

Universitätsmedizin Berlin - Charité, Berlin

50937

University Hospital Cologne, Cologne

52074

Universitätsklinikum Aachen, Aachen

80804

Klinikum Schwabing, Munich

81737

Klinikum Neuperlach, Munich

All Listed Sponsors
collaborator

3M

INDUSTRY

lead

University of Cologne

OTHER

NCT01544686 - Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients | Biotech Hunter | Biotech Hunter